Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: SVP and CCO
Company: JW Therapeutics Co., Ltd
个人简介:
Mr. Alex Wu joined JW Therapeutics on September 8, 2020, as Senior Vice President (SVP) and Chief Commercial Officer (CCO) and is in charge of the overall commercial function and operations.  Mr. Wu has been in the healthcare industry for 26 years. Before joining JW Therapeutics, Mr. Wu was an Assistant Vice President (AVP) and General Manager of Hospital Specialty Business in MSD China. Prior to that, he has worked in Baxter China, Xian Janssen, and Danone China. During his tenure, he has achieved the following outstanding results: Led the first region to launch Cozaar and made it a market leader; Accelerated the growth of Proscar in the Chinese market to surpass both UK and US markets to be the No.1 in MSD globally; Built a win-win partnership with the Ministry of Health (now known as the National Health Commission of the PRC) to promote the peritoneal dialysis (PD) therapy together in China, and turned around Baxter China’s hospital products (HP) business into a profitable and sustainable one.   Mr. Wu received his Bachelor’s degree in Medical Analysis from China Pharmaceutical University and an EMBA (Executive Master of Business Administration) degree from China Europe International Business School (CEIBS).
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: Chief Commercial Officer
Company: HARBOUR BIOMED
个人简介:
Dr. Mai-Jing Liao brings to HBM more than 12 years of Marketing and Business Development experience. Prior to joining HBM, Dr. Liao was at Xian Janssen Pharmaceutical Ltd. where he served in multiple roles with increasing responsibilities in Marketing, Strategic Marketing and Business Development. He joined J&J's Centocor US subsidiary after receiving his MBA degree from Johnson Graduate School of Management at Cornell University.Dr. Liao received his PhD degree in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill and was a postdoctoral fellow in Dr. Robert Weinberg's laboratory at Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology (MIT).
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: Chief Medical Officer
Company: Alphamab Oncology
个人简介:
Johannes Nippgen, MD, PhD, is Chief Medical Officer for Alphamab Oncology康宁杰瑞.  He passionately aspires to innovation and improvement and strives towards bringing healthcare R&D in China to global leadership. After graduating in Medicine in Mainz, Germany, and earning his doctorate in Wurzburg, Germany, Johannes started his professional career as surgical oncologist.  He holds German and European board certifications in Urology/ GU-oncology and published in various regional and international journals including the New England Journal of Medicine. Before joined Alphamab Oncology, he was the Head of R&D for Merck China.
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: CBO
Company: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
个人简介:
Dr. Zhu has more than 20 years of experience in the pharmaceutical industry and worked with both global pharmaceutical companies (Pfizer and JNJ) and Chinese pharmaceutical company. He has done 28 strategic transactions (total value US$3 billion) including the 2 recent landmark deals in China, the Joint Venture agreement between Amgen and Betta Pharma to commercialize Amgen’s Vectibix (panitumumab) in China for colorectal cancer patients in May 2013, and the US$20 million strategic investment in Xcovery by Betta Pharma and acquired the China right of Ensartinib in October 2014.